On November 10, 2020 Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer, and other indications, reported that members of the management team will participate in the following upcoming investor conferences (Press release, Pieris Pharmaceuticals, NOV 10, 2020, View Source [SID1234570469]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies Virtual London Healthcare Conference
Tuesday, November 17, 2020 at 3:50PM GMT. A webcast of the Company’s fireside chat will be available at this link.
3rd Annual Evercore ISI HealthCONx Conference
Tuesday, December 1, 2020 at 3:30PM EST. A webcast of the Company’s fireside chat will be available at this link.